A Mangili1, I Bica, D R Snydman
1Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA. AMangili@tufts-NEMC.org
Daptomycin resistance developed in a patient with methicillin-resistant Staphylococcus aureus (MRSA) during treatment for septic portal vein thrombophlebitis. This highlights the risk of resistance with prolonged daptomycin use in persistent MRSA infections.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: